Nimorazole and its Impurities

Nimorazole has been used in trials studying the treatment of Hypoxia, Radiotherapy, Hypoxic Modification, Gene Profile, Gene Signature, and Head and Neck Squamous Cell Carcinoma, among others. It is a nitroimidazole anti-infective.Reference standards of Nimorazole API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 5 results for Nimorazole Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 41 0091000

4-(2-Chloroethyl)morpholine Hydrochloride

4-(2-Chloroethyl)morpholine Hydrochloride


  • Catalogue No.:PA 41 0091000

  • CAS :

    3647-69-6

  • Molecular Formula : C6H13Cl2NO

  • Molecular Weight : 186.08

Drug Reference Standards & Impurity Synthesis in India
PA 41 09000

Nimorazole

Nimorazole


  • Catalogue No.:PA 41 09000

  • CAS :

    6506-37-2

  • Molecular Formula : C9H14N4O3

  • Molecular Weight : 226.24

Drug Reference Standards & Impurity Synthesis in India
PA 41 09520

4-(2-(1H-Imidazol-1-yl)ethyl)Morpholine

4-(2-(1H-Imidazol-1-yl)ethyl)Morpholine


  • Catalogue No.:PA 41 09520

  • CAS :

    18994-82-6

  • Molecular Formula : C9H15N3O

  • Molecular Weight : 181.24

Drug Reference Standards & Impurity Synthesis in India
PA 41 09510

4-[2-(4-Nitro-1H-imidazol-1-yl)ethyl]morpholine

4-[2-(4-Nitro-1H-imidazol-1-yl)ethyl]morpholine


  • Catalogue No.:PA 41 09510

  • CAS :

    6497-78-5

  • Molecular Formula : C9H14N4O3

  • Molecular Weight : 226.24

Drug Reference Standards & Impurity Synthesis in India
PA BSC 0094101216

4-(2-Chloroethyl)morpholine Hydrochloride (BSC)

4-(2-Chloroethyl)morpholine Hydrochloride (BSC)


  • Catalogue No.:PA BSC 0094101216

  • CAS :

    3647-69-6

  • Molecular Formula : C6H13Cl2NO

  • Molecular Weight : 186.08

pharmaffiliates